A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema